Evans John M. — SEC Form 4 filings
SEC reporting owner CIK 1786304. 14 Form 4 filings on record with FilingPulse; latest filed 2026-07-01.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-02-02 to 2026-07-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 21 legs across 12 filings — 548,843 shares, $14,728,688 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 30.
- Largest priced transaction: sale of 60,000 shares @ $33.86 ($2,031,402) in Beam Therapeutics Inc., filed 2024-04-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | CEO, Director | 14 | — | 21 legs · 548,843 sh · $14,728,688 | 30 |
Form 4 filings — Evans John M.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-01 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 18,663 @ $0.67 · Option exercise (M): 6,337 @ $1.03 · Sale (S): 13,421 @ $35.13 · Sale (S): 11,579 @ $35.91 · Option exercise (M): 25,000 @ $1.03 · Sale (S): 23,100 @ $34.26 · +4 more | EDGAR |
| 2026-04-06 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 30,078 @ $24.58 | EDGAR |
| 2026-04-01 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 25,000 @ $0.67 · Sale (S): 25,000 @ $22.37 · Option exercise (M): 25,000 @ $0.67 · Sale (S): 25,000 @ $22.76 · Grant/award (A): 90,000 @ $0 · Option exercise (M): 25,000 (derivative) @ $0 · +1 more | EDGAR |
| 2026-02-02 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 19,336 @ $0.67 · Option exercise (M): 5,664 @ $0.67 · Sale (S): 16,333 @ $29.19 · Sale (S): 8,667 @ $29.74 · Option exercise (M): 25,000 @ $0.67 · Sale (S): 22,094 @ $28.27 · +5 more | EDGAR |
| 2025-10-03 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 25,000 @ $0.67 · Sale (S): 25,000 @ $24.51 · Option exercise (M): 25,000 @ $0.67 · Sale (S): 25,000 @ $24.63 · Option exercise (M): 25,000 (derivative) @ $0 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 30,663 @ $18.35 | EDGAR |
| 2025-04-02 | 4/A | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 30,000 @ $0.67 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 77,500 @ $0 | EDGAR |
| 2025-02-03 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 29,800 @ $26.75 · Sale (S): 200 @ $27.28 · Grant/award (A): 155,000 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 60,000 @ $24.60 | EDGAR |
| 2024-06-28 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 60,000 @ $24.50 | EDGAR |
| 2024-04-03 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 18,102 @ $32.13 · Grant/award (A): 99,336 (derivative) @ $0 · Grant/award (A): 53,965 (derivative) @ $0 | EDGAR |
| 2024-04-01 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 60,000 @ $33.86 · Grant/award (A): 77,500 @ $0 | EDGAR |
| 2024-02-02 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 60,000 @ $25.33 · Grant/award (A): 155,000 (derivative) @ $24.40 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1786304 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →